Zusammenfassung
Die Lasertrabekuloplastik ist eine weit verbreitete Glaukomtherapie, die sicher und effektiv den Augeninnendruck senken kann. Sie wurde in den 1970er Jahren zur Behandlung von Offenwinkelglaukomen entwickelt und konnte in der Folge ihre Wirksamkeit in größeren Studien belegen. In den letzten Jahren hat die Lasertrabekuloplastik durch die Einführung neuerer Verfahren wie der selektiven Lasertrabekuloplastik eine Weiterentwicklung erlebt, die aufgrund geringerer Schädigung im Trabekelwerk wiederholbar und nebenwirkungsärmer sein soll. Im folgenden Beitrag wird die Studienlage hinsichtlich der Wirksamkeit, Indikation und Kontraindikation in der drucksenkenden Therapie dargestellt.
Abstract
Laser trabeculoplasty is a common glaucoma therapy that is safe and effective for reducing intraocular pressure. It was developed as a treatment for open-angle glaucoma in the 1970s, and larger studies proved its effectiveness in the years that followed. In recent years, through the implementation of newer processes such as selective laser trabeculoplasty, laser trabeculoplasty has experienced further developments. Because it causes less damage to the trabecular meshwork, it should have fewer adverse effects, making it a repeatable treatment. Studies on the indications, contraindications, and effectiveness of this method in lowering intraocular pressure are reviewed.
Literatur
Agarwal HC, Sihota R, Das C, Dada T (2002) Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol 86:733–736
Best UP, Domack H, Schmidt V (2005) Langzeitergebnisse nach selektiver Lasertrabekuloplastik – eine klinische Studie an 269 Augen. Klin Monatsbl Augenheilkd 222:326–331
Birt CM (2007) Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Can J Ophthalmol 42(5):715–719
Chen E, Golchin S, Blomdahl S (2004) A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma 13(1):62–65
Cvenkel B (2004) One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica 218(1):20–25
Damji KF, Bovell AM, Hodge WG et al (2006) Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol 90:1490–1494
Detry-Morel M, Muschart F, Pourjavan S (2008) Micropulse diode laser (810 nm) vesus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile. Bull Soc Belge Ophtalmol 308:21–28
Englert JA, Cox TA, Allingham RR, Shields MB (1997) Argon vs diode laser trabeculoplasty. Am J Ophthalmol 124(5):627–631
Francis BA, Ianchulev T, Schofield JK, Minckler DS (2005) Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma. Am J Ophthalmol 140:524–525
Glaucoma Laser Trial Research Group (1995) The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study: 7 Results. Am J Ophthalmol 120:718–731
Gracner T, Falez M, Gracner B, Pahor D (2006) Langfristige Nachbeobachtung der selektiven Lasertrabekuloplastik bei primärem Offenwinkelglaukom. Klin Monatsbl Augenheilkd 223:743–747
Johnson PB, Katz LJ, Rhee DJ (2006) Selective laser trabeculoplasty: predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol 90:741–743
Juzych MS, Chopra V, Banitt MR et al (2004) Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 111:1853–1859
Latina MA, Park C (1995) Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 60(4):359–371
Latina MA, Sibayan SA, Shin DH et al (1998) Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 105(11):2082–2088
Mahar PS, Jamali KK (2008) Argon laser trabeculoplasty as primary therapy in open angle glaucoma. J Coll Physicians Surg Pak 18(2):102–104
Martinez de la Casa JM, Garcia-Feijoo J, Castillo A et al (2004) Selective vs. argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation and postoperative pain. Eye 18(5):498–502
McIlraith I, Strasfeld M, Colev G, Hutnik CM (2006) Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 15(2):124–130
Moriarty AP, McHugh JD, Ffytche TJ et al (1993) Long-term follow-up of diode laser trabeculoplasty for primary open-angle glaucoma and ocular hypertension. Ophthalmology 100(11):1614–1618
Nagar M, Ogunyomade A, O‘Brart DP et al (2005) A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 89:1413–1417
Pirnazar JR, Kolker AE, Wax MB, Kass MA (1998) The efficacy of 532 nm laser trabeculoplasty. Invest Ophthalmol Vis Sci 39:5
Rasmussen CA, Kaufman PL (2005) Primate glaucoma models. J Glaucoma 14:311–314
Richter CU, Shingleton BJ, Bellows AR et al (1987) Retreatment with argon laser trabeculoplasty. Ophthalmology 94(9):1085–1089
Russo V, Barone A, Cosma A et al (2009) Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. Eur J Ophthalmol 19(3):429–434
Weinand FS, Althen F (2006) Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 16:100–104
Wise JB, Witter SL (1979) Argon laser therapy for open angle glaucoma: a pilot study. Arch Ophthalmol 97:319–322
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eckert, S. Effektivität und Stellenwert der Lasertrabekuloplastik. Ophthalmologe 107, 18–21 (2010). https://doi.org/10.1007/s00347-009-2053-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-009-2053-7